APA (7th ed.) Citation

Rotundo, M., Bini, C., Marcellusi, A., & Mennini, F. (2019). PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY. Value in Health, 22, S599. https://doi.org/10.1016/j.jval.2019.09.1028

Chicago Style (17th ed.) Citation

Rotundo, M., C. Bini, A. Marcellusi, and F.S Mennini. "PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY." Value in Health 22 (2019): S599. https://doi.org/10.1016/j.jval.2019.09.1028.

MLA (9th ed.) Citation

Rotundo, M., et al. "PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY." Value in Health, vol. 22, 2019, p. S599, https://doi.org/10.1016/j.jval.2019.09.1028.